Buspirone Can Cause Nasal Congestion as a Known Side Effect
Yes, buspirone (Buspar) can cause a runny nose—this is a documented adverse effect listed in the FDA drug label as "nasal congestion," occurring frequently (in at least 1/100 patients). 1
What the Evidence Shows
The FDA prescribing information for buspirone explicitly lists nasal congestion under the EENT (Eyes, Ears, Nose, Throat) category as a frequent adverse event occurring in at least 1% of patients 1. The same source also documents "sore throat" and "tinnitus" as frequent EENT effects, while "redness and itching of the eyes" are listed as infrequent reactions 1.
Timing and Pattern Considerations
Your patient's experience—tolerating the first dose but developing symptoms after the second dose—is consistent with:
- Early medication exposure reactions: Many buspirone side effects emerge within the first week of treatment
- Dose-dependent effects: The second dose represents cumulative drug exposure, as buspirone reaches steady-state levels
- Individual sensitivity: Some patients manifest side effects only after initial drug accumulation
The median time to onset for buspirone adverse events is 10 days (based on recent pharmacovigilance data), though symptoms can appear earlier 2.
Clinical Decision-Making
This is likely a medication side effect if:
- The runny nose started temporally related to buspirone initiation
- No other concurrent upper respiratory infection symptoms (fever, body aches, productive cough)
- The symptom pattern correlates with dosing
Consider alternative explanations:
- Coincidental viral upper respiratory infection (common this time of year)
- Allergic rhinitis triggered by environmental factors
- True drug allergy (though this would be rare and typically presents with additional symptoms)
Management Approach
Continue the medication and monitor closely if the runny nose is the only symptom and is mild. The FDA data shows nasal congestion is a recognized, generally benign side effect that may resolve with continued use as tolerance develops 1.
Discontinue immediately if the patient develops:
- Urticaria, angioedema, or skin rash (documented allergic reactions in postmarketing surveillance) 1
- Difficulty breathing or wheezing
- Progressive worsening of symptoms
- Multiple concurrent adverse effects
Important Caveats
- Allergic reactions to buspirone are rare but documented in postmarketing experience, including urticaria and angioedema 1
- The distinction between a benign side effect (nasal congestion) and an early allergic reaction (itchy/runny nose as prodrome) requires clinical judgment
- If the patient describes itching prominently rather than just congestion, maintain higher suspicion for allergic reaction
- One week is early in treatment—many side effects diminish after 2-4 weeks of continued therapy 3
Most common reasons for discontinuation in clinical trials were CNS effects (dizziness, nervousness, drowsiness) at 3.4% and GI disturbances at 1.2%—not nasal symptoms 1. This suggests nasal congestion alone rarely necessitates stopping the medication.